IMTX Immatics N.V.

NEUTRAL Impact: 3/10 6-K
Horizon weeks Filed Jun 2, 2026 Processed 12d 21h ago SEC 0000950103-26-008259
Notable filing: 6-K
Latest settled — T+1d ⚠ clustered
IMTX ▲ +1.64% at T+1d
NEUTRAL call ✓ call won +1.64% · α vs SPY +2.34% · entry $10.04 → $10.21
Next anchor: T+5d due 6d ago
Last close $9.38 (close Jun 12) · -6.57% from $10.04 entry
Entry anchored
Jun 1, 03:59 PM ET
via Databento tick
T+1d
+1.64%
call +1.64% · α +2.34%
$10.21
settled 12d ago
T+5d
call — · α —
due 6d ago
T+20d
call — · α —
in 16d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Immatics N.V. filed a 6-K on June 2, 2026, convening its Annual General Meeting (AGM) scheduled for June 18, 2026. The AGM agenda includes routine items such as adoption of statutory annual accounts, discharge of directors, reappointment of three directors (CEO Harpreet Singh, non-executive directors Mathias Hothum and Adam Stone), extension of board authorization for share repurchases, approval of a new 2026 Stock Option and Incentive Plan reserving 6,448,836 shares, and reappointment of PwC as auditor. The filing is a routine governance update with no material financial data or operational catalysts.

Actionable Insight

This is a routine governance filing with no immediate trading catalyst. Monitor the AGM outcome on June 18 for approval of the equity plan and share repurchase authorization, which could signal future capital allocation priorities. No earnings or operational data was released.

Key Facts

  • AGM scheduled for June 18, 2026 in Amsterdam; record date May 21, 2026.
  • Proposed 2026 Stock Option and Incentive Plan reserves 6,448,836 ordinary shares for issuance.
  • Board seeks extension of authorization to repurchase ordinary shares for 18 months at up to 110% of market price.
  • Reappointment of CEO Harpreet Singh as executive director for a 3-year term ending at the 2029 AGM.
  • Reappointment of non-executive directors Mathias Hothum and Adam Stone for 3-year terms.
  • PwC proposed as auditor for FY 2026.
  • No financial results, guidance, or material operational updates were provided in this filing.

Financial Impact

No financial figures reported. The new equity incentive plan authorizes up to 6,448,836 shares (approximately 3-4% dilution based on current share count, but no actual grants have been made).

dilution

Risk Factors

  • Potential future dilution from the 2026 equity incentive plan if fully utilized.
  • No material business or financial updates — stock price movement unlikely from this filing alone.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
94% bullish (18 analysts)

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0000950103-26-008259
Document: dp247175_ex9902.htm0000950103-26-008259
Document: dp247175_ex9901.htm0000950103-26-008259
Document: dp247175_6k.htm0000950103-26-008259
Document: 0000950103-26-008259-index-headers.html0000950103-26-008259
Document: 0000950103-26-008259-index.html0000950103-26-008259
Document: 0000950103-26-008259.txt0000950103-26-008259
12 reports for IMTX
Performance horizon
56% Hit rate 5 of 9 directional calls best @ T+5▲ +6.76%May 12, 2026
Filters
Rows
Reports for IMTX — sortable, filterable
Type Now
Jun 2, 2026
12d ago
6-K
NEUTRAL ★ 3/10
$10.04 $10.21▲ +1.64%▲ +2.34%$9.38 (−6.57%)
Jun 1, 2026
13d ago
6-K
BULLISH ★ 7/10
$11.14 $10.04▼ −9.87%▼ −10.02%$9.38 (−15.80%)
Jun 1, 2026
13d ago
Press Release
BULLISH ★ 6/10
$11.14 $10.04▼ −9.87%▼ −10.02%$9.38 (−15.80%)
May 31, 2026
14d ago
Press Release
BULLISH ★ 6/10
$11.14 $10.04▼ −9.87%▼ −10.02%$9.38 (−15.80%)
May 30, 2026
15d ago
Press Release
BULLISH ★ 7/10
$11.14 $10.04▼ −9.87%▼ −10.02%$9.38 (−15.80%)
May 12, 2026
4w ago
6-K
BEARISH ★ 6/10
$11.39 $10.79▲ +5.27%▲ +5.84%$9.38 (+17.65%)
May 12, 2026
4w ago
Press Release
MIXED ★ 6/10
$11.39 $10.79▼ −5.27%▼ −5.84%$9.38 (−17.65%)
Apr 21, 2026
7w ago
6-K
BULLISH ★ 7/10
$11.18 $11.26▲ +0.72%▼ −0.30%$9.38 (−16.10%)
Apr 21, 2026
7w ago
Press Release
BULLISH ★ 7/10
$11.18 $11.26▲ +0.72%▼ −0.30%$9.38 (−16.10%)
Apr 17, 2026
8w ago
6-K
BULLISH ★ 8/10
$11.17 $11.25▲ +0.72%▲ +0.91%$9.38 (−16.03%)
Showing 10 of 12

US Market Status

Market Closed — Opens in 3h 58m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access